The Cancer Letter

Inside information on cancer research and drug development

Vol.
33
No.
11
November 26, 2010Nov 26, 2010
Free
DOWNLOAD THE PDF

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

Patients Prefer Silicone Over Saline Implants

More Breast Cancer Patients Opt To Remove Both Breasts

Small Study: Radiation, Chemo May Better Control Anal Cancer

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

Clinical Trials Approved By NCI

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account